Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (viagra): a report of seven new cases
- PMID: 15756125
- DOI: 10.1097/00041327-200503000-00003
Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (viagra): a report of seven new cases
Abstract
Seven patients, aged between 50 and 69 years, had typical features of nonarteritic anterior ischemic optic neuropathy (NAION) within 36 hours after ingestion of sildenafil citrate (Viagra) for erectile dysfunction. Six patients had vision loss within 24 hours after use of the agent. Final visual acuity in the affected eye ranged from 20/20 to light perception. Both eyes were affected in one individual. All affected individuals had pre-existing hypertension, diabetes, elevated cholesterol, or hyperlipidemia. Seven similar cases have been previously reported. Sildenafil may provoke NAION in individuals with an arteriosclerotic risk profile.
Comment in
-
Non-arteritic anterior ischemic optic neuropathy, erectile dysfunction drugs, and amiodarone: is there a relationship?J Neuroophthalmol. 2006 Mar;26(1):1-3. doi: 10.1097/01.wno.0000205622.45263.ad. J Neuroophthalmol. 2006. PMID: 16518158 No abstract available.
Similar articles
-
Sildenafil-associated nonarteritic anterior ischemic optic neuropathy.Ophthalmology. 2002 Mar;109(3):584-7. doi: 10.1016/s0161-6420(01)00976-9. Ophthalmology. 2002. PMID: 11874765
-
Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy.Int J Clin Pract. 2006 Apr;60(4):500-3. doi: 10.1111/j.1368-5031.2006.00904.x. Int J Clin Pract. 2006. PMID: 16620369 Free PMC article.
-
Anterior ischemic optic neuropathy associated with viagra.J Neuroophthalmol. 2001 Mar;21(1):22-5. doi: 10.1097/00041327-200103000-00006. J Neuroophthalmol. 2001. PMID: 11315976
-
Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction.J Sex Med. 2006 Jan;3(1):12-27. doi: 10.1111/j.1743-6109.2005.00194.x. J Sex Med. 2006. PMID: 16409214 Review.
-
Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship?J Neuroophthalmol. 2005 Dec;25(4):295-8. doi: 10.1097/01.wno.0000189059.90057.98. J Neuroophthalmol. 2005. PMID: 16340497 Review.
Cited by
-
Non-Arteritic Anterior Ischemic Optic Neuropathy Associated With the Use of Phosphodiesterase Type 5 Inhibitors: A Literature Review.Cureus. 2022 Aug 3;14(8):e27642. doi: 10.7759/cureus.27642. eCollection 2022 Aug. Cureus. 2022. PMID: 36072219 Free PMC article. Review.
-
Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review.J Ophthalmic Vis Res. 2021 Apr 29;16(2):248-259. doi: 10.18502/jovr.v16i2.9088. eCollection 2021 Apr-Jun. J Ophthalmic Vis Res. 2021. PMID: 34055262 Free PMC article. Review.
-
Effects of phosphodiesterase type 5 inhibitors on choroid and ocular vasculature: a literature review.Int J Retina Vitreous. 2020 Aug 6;6:38. doi: 10.1186/s40942-020-00241-0. eCollection 2020. Int J Retina Vitreous. 2020. PMID: 32782824 Free PMC article. Review.
-
Association Study of MTHFR Polymorphisms with Nonarteritic Anterior Ischemic Optic Neuropathy in a Spanish Population.Biomed Hub. 2020 Jan 21;5(1):34-46. doi: 10.1159/000505431. eCollection 2020 Jan-Apr. Biomed Hub. 2020. PMID: 32775330 Free PMC article.
-
Ocular Side Effects of Systemic Drugs Used in Dermatology.Indian J Dermatol. 2019 Nov-Dec;64(6):423-430. doi: 10.4103/ijd.IJD_353_18. Indian J Dermatol. 2019. PMID: 31896837 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
